D W Townsend
Overview
Explore the profile of D W Townsend including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1643
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dachille M, Beyer T, Townsend D, Meltzer C, Jerin J
Clin Positron Imaging
. 2003 Oct;
1(4):236.
PMID: 14516559
No abstract available.
12.
Beyer T, Townsend D, Blodgett T
Q J Nucl Med
. 2002 Jun;
46(1):24-34.
PMID: 12072843
Diagnosis and follow-up in clinical oncology are traditionally based on computed tomography (CT). In recent years, however, functional imaging using positron emission tomography (PET) has been recognized as an important...
13.
Derbyshire S, Jones A, Creed F, Starz T, Meltzer C, Townsend D, et al.
Neuroimage
. 2002 Apr;
16(1):158-68.
PMID: 11969326
Changes in regional cerebral blood flow (rCBF) have previously been demonstrated in a number of cortical and subcortical regions, including the cerebellum, midbrain, thalamus, lentiform nucleus, and the insula, prefrontal,...
14.
Makhija S, Howden N, Edwards R, Kelley J, Townsend D, Meltzer C
Gynecol Oncol
. 2002 Apr;
85(1):53-8.
PMID: 11925120
Purpose: Imaging modalities to evaluate ovarian/fallopian tube cancer patients for recurrence are limited. Positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound lack the sensitivity to...
15.
Townsend D, Cherry S
Eur Radiol
. 2001 Nov;
11(10):1968-74.
PMID: 11702130
Modern imaging technologies visualize different aspects of disease in a non-invasive way. Considerable progress has been made in the fusion of images from different imaging modalities using software approaches. One...
16.
Kluetz P, Meltzer C, Villemagne V, Kinahan P, Chander S, Martinelli M, et al.
Clin Positron Imaging
. 2001 May;
3(6):223-230.
PMID: 11378434
Purpose: In this work, we describe five oncology patients whose clinical management were uniquely benefited by a novel scanner that acquires positron emission tomography (PET) and x-ray computed tomography (CT)...
17.
Heller M, Meltzer C, Fukui M, Rosen C, Chander S, Martinelli M, et al.
Clin Positron Imaging
. 2001 May;
3(5):207-211.
PMID: 11348849
The application of positron emission tomography imaging with 18F-fluorodeoxyglucose (FDG) to the extracranial head and neck has been proven to be effective in the detection and staging of malignancy. The...
18.
19.
Charron M, Beyer T, Bohnen N, Kinahan P, Dachille M, Jerin J, et al.
Clin Nucl Med
. 2000 Nov;
25(11):905-10.
PMID: 11079589
Purpose: To compare combined whole-body PET and CT images of different cancers with PET images alone. Materials And Methods: Thirty-two patients with known or possible cancers were examined using a...
20.
Meltzer C, Luketich J, Friedman D, Charron M, Strollo D, Meehan M, et al.
Clin Nucl Med
. 2000 Nov;
25(11):882-7.
PMID: 11079584
Purpose: The aim of the authors in this study was to critically evaluate the role of whole-body positron emission tomographic (PET) imaging with fluorine-18 fluorodeoxyglucose (FDG) in staging esophageal cancer,...